AI Article Synopsis
- Study aimed to assess if zinc supplementation affects mood in older Europeans, focusing on doses of 15 mg/d and 30 mg/d, compared to a placebo.
- The study involved 387 healthy volunteers aged 55-87 from various locations in Italy, France, and Northern Ireland.
- Results showed no significant changes in positive or negative mood in response to zinc supplementation, indicating it does not improve mood in healthy older adults.
Article Abstract
Objective: Older people are vulnerable to zinc deficiency, which may impact upon their mood. This randomised, placebo-controlled, double-blind intervention study aimed to investigate the effect of oral zinc gluconate supplementation (15 mg/d; 30 mg/d; and placebo) on subjective mood (affect) in older Europeans.
Subjects: Healthy volunteers (n 387) aged 55-87 years were recruited.
Setting: Volunteers in Rome (Italy; n 108) and Grenoble (France; n 91) were aged 70-87 years and those in Coleraine (Northern Ireland; n 93) and Clermont-Ferrand (France; n 95) were aged 55-70 years.
Design: Mood was measured using the Positive and Negative Affect Scale on four occasions per day over 4 d at baseline, 3 and 6 months post-intervention.
Results: Mixed ANOVA indicated that neither positive nor negative affect altered in response to zinc (15 mg/d or 30 mg/d) compared to placebo in either the 55-70 years or the ≥70 years age group.
Conclusions: These results suggest that zinc does not benefit mood in healthy older people.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1017/S1368980010002764 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!